Novo Holdings Invests in Manipal Hospitals

Temasek Acquires Additional 41% Stake in Manipal Health Enterprises

April 10, 2023

Healthcare Services

Temasek has signed definitive agreements to acquire an additional 41% stake in Manipal Health Enterprises (MHE), increasing its investment in the India-based hospital network. Following the transaction, Manipal Group will hold about 30%, Sheares Healthcare Group (a Temasek subsidiary) will retain 18%, TPG will re-invest an 11% interest through TPG Asia VIII, and NIIF will exit its holding.

Novo Holdings Invests in Oxford Biomedica plc

May 28, 2019

Biotechnology

Novo Holdings A/S agreed to invest up to £53.5 million in new ordinary shares of Oxford Biomedica plc, taking up to a 10.1% stake. The proceeds will be used to repay an existing Oaktree debt facility in full and to scale Oxford Biomedica's LentiVector platform and proprietary product portfolio.

Novo Holdings Leads $50M Growth Investment in MedGenome

August 30, 2022

Biotechnology

Novo Holdings led a $50 million minority investment in MedGenome alongside existing investors LeapFrog Investments and Sofina. The capital will support MedGenome’s expansion beyond South Asia into Africa and the Middle East and broaden access to its genomic testing, bioinformatics and research services.

Novo Holdings Invests £50m in Oxford Nanopore Technologies

August 1, 2024

Biotechnology

Novo Holdings has invested £50 million in UK-listed Oxford Nanopore Technologies via an equity issue and intends to make further share purchases in the secondary market. The investment is intended to support Oxford Nanopore's commercial growth and capability expansion in biopharmaceutical and biomanufacturing markets.

Novo Holdings Acquires Medical Knowledge Group

January 3, 2022

Healthcare Services

Novo Holdings A/S has agreed to acquire Medical Knowledge Group (MKG) from Court Square Capital and Aisling Capital. MKG is an analytics-driven, technology-enabled drug commercialisation and medical communications platform headquartered in New York with more than 500 employees; Novo said the acquisition will support MKG's continued growth in biopharmaceutical commercialisation services.

Novo Holdings Acquires KabaFusion from Pritzker Private Capital

November 2, 2022

Healthcare Services

Novo Holdings has acquired KabaFusion, a national provider of home infusion therapies, from Pritzker Private Capital. KabaFusion's clinician-led management team will remain significant investors and will continue to run the business as Novo supports continued growth and expansion of its nationwide home infusion network.